Acquisition of Shares and Investments to Strengthen Business Collaboration
First written in FY2023. . Latest entry: FY2026.
2 other companies' latest entry also says "Other".
- FY2026Investments sold while others are retainedAnnual report
「This was mainly attributable to ¥1,892 million in proceeds from the sale of investments accounted for under the equity method and ¥567 million in partial proceeds received for the transfer of shares.」
While investments made for business partnership purposes, including equity-method investments, are being monetised through sales, holdings retained to maintain partnerships, such as shares in Virtualex Holdings, continue to be held. - FY2026-H1Monetisation through the sale of investment interestsAnnual report
「This was mainly attributable to ¥1,892 million in proceeds from the sale of investments accounted for under the equity method and ¥567 million in partial proceeds received for the transfer of shares.」
The company received ¥1,892 million from the sale of investments accounted for under the equity method and ¥567 million in partial proceeds received for the transfer of shares. The company additionally disclosed the sale and monetisation of investments made for business partnership purposes. - FY2025Sale and continued retention of equity holdingsAnnual report
「Money Partners Group, Inc. The shares were held to strengthen the partnership with our group, but all shares have been sold following the tender offer conducted by Gaitame.com Co., Ltd. Virtualex Holdings, Inc. The shares are held to maintain the partnership with our group and to receive ongoing, stable support from the company as a key business partner.」
The company sold all of its shares in Money Partners Group, which had been held to strengthen the partnership, while continuing to hold shares in Virtualex Holdings to maintain the partnership. - FY2023First statedAnnual report
「Acquisition of shares to strengthen business partnerships」
The company is making investments to strengthen business partnerships, including the acquisition of shares in SIMPLEX QUANTUM Co., Ltd., Pathoslogos Co., Ltd. and others.